North America Sickle Cell Disease Treatment Market Size, Share & Industry Trends Analysis Report By Treatment (Blood Transfusion, Pharmacotherapy, and Bone Marrow Transplant), By End-Use (Hospitals, Specialty Clinics), By Country and Growth Forecast, 2023 - 2030

TABLE 1 North America Sickle Cell Disease Treatment Market, 2019 - 2022, USD Million
TABLE 2 North America Sickle Cell Disease Treatment Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Sickle Cell Disease Treatment Market
TABLE 4 Product Launches And Product Expansions– Sickle Cell Disease Treatment Market
TABLE 5 Acquisition and Mergers– Sickle Cell Disease Treatment Market
TABLE 6 Trials and Approvals- SICKLE Cell Disease Treatment Market
TABLE 7 North America Sickle Cell Disease Treatment Market by Treatment, 2019 - 2022, USD Million
TABLE 8 North America Sickle Cell Disease Treatment Market by Treatment, 2023 - 2030, USD Million
TABLE 9 North America Blood Transfusion Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Blood Transfusion Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Pharmacotherapy Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Pharmacotherapy Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Bone Marrow Transplant Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Bone Marrow Transplant Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Sickle Cell Disease Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 16 North America Sickle Cell Disease Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 17 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Specialty Clinics Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Specialty Clinics Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Sickle Cell Disease Treatment Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Sickle Cell Disease Treatment Market by Country, 2023 - 2030, USD Million
TABLE 25 US Sickle Cell Disease Treatment Market, 2019 - 2022, USD Million
TABLE 26 US Sickle Cell Disease Treatment Market, 2023 - 2030, USD Million
TABLE 27 US Sickle Cell Disease Treatment Market by Treatment, 2019 - 2022, USD Million
TABLE 28 US Sickle Cell Disease Treatment Market by Treatment, 2023 - 2030, USD Million
TABLE 29 US Sickle Cell Disease Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 30 US Sickle Cell Disease Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 31 Canada Sickle Cell Disease Treatment Market, 2019 - 2022, USD Million
TABLE 32 Canada Sickle Cell Disease Treatment Market, 2023 - 2030, USD Million
TABLE 33 Canada Sickle Cell Disease Treatment Market by Treatment, 2019 - 2022, USD Million
TABLE 34 Canada Sickle Cell Disease Treatment Market by Treatment, 2023 - 2030, USD Million
TABLE 35 Canada Sickle Cell Disease Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 36 Canada Sickle Cell Disease Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 37 Mexico Sickle Cell Disease Treatment Market, 2019 - 2022, USD Million
TABLE 38 Mexico Sickle Cell Disease Treatment Market, 2023 - 2030, USD Million
TABLE 39 Mexico Sickle Cell Disease Treatment Market by Treatment, 2019 - 2022, USD Million
TABLE 40 Mexico Sickle Cell Disease Treatment Market by Treatment, 2023 - 2030, USD Million
TABLE 41 Mexico Sickle Cell Disease Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 42 Mexico Sickle Cell Disease Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 43 Rest of North America Sickle Cell Disease Treatment Market, 2019 - 2022, USD Million
TABLE 44 Rest of North America Sickle Cell Disease Treatment Market, 2023 - 2030, USD Million
TABLE 45 Rest of North America Sickle Cell Disease Treatment Market by Treatment, 2019 - 2022, USD Million
TABLE 46 Rest of North America Sickle Cell Disease Treatment Market by Treatment, 2023 - 2030, USD Million
TABLE 47 Rest of North America Sickle Cell Disease Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 48 Rest of North America Sickle Cell Disease Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 49 Key Information – bluebird bio, Inc.
TABLE 50 Key Information – CRISPR Therapeutics AG
TABLE 51 Key Information – Agios Pharmaceuticals, Inc.
TABLE 52 Key Information – Medunik USA
TABLE 53 Key Information – CSL Limited
TABLE 54 Key Information – Novo Nordisk A/S
TABLE 55 Key Information – Novartis AG
TABLE 56 Key Information – Pfizer, Inc.
TABLE 57 Key Information – Bristol Myers Squibb Company
TABLE 58 Key Information – Emmaus Life Sciences, INC.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Sickle Cell Disease Treatment Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Sickle Cell Disease Treatment Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: Partnerships, Collaborations & Agreements: 2019, Feb – 2022, Jun) Leading Players
FIG 7 Porter’s Five Forces Analysis – Sickle Cell Disease Treatment Market
FIG 8 North America Sickle Cell Disease Treatment Market share by Treatment, 2022
FIG 9 North America Sickle Cell Disease Treatment Market shar by Treatment, 2030
FIG 10 North America Sickle Cell Disease Treatment Market by Treatment, 2019 - 2030, USD Million
FIG 11 North America Sickle Cell Disease Treatment Market share by End-use, 2022
FIG 12 North America Sickle Cell Disease Treatment Market shar by End-use, 2030
FIG 13 North America Sickle Cell Disease Treatment Market by End-use, 2019 - 2030, USD Million
FIG 14 North America Sickle Cell Disease Treatment Market share by Country, 2022
FIG 15 North America Sickle Cell Disease Treatment Market share by Country, 2030
FIG 16 North America Sickle Cell Disease Treatment Market by COuntry, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: bluebird bio, Inc.
FIG 18 SWOT Analysis: CRISPR Therapeutics AG
FIG 19 SWOT Analysis: Agios Pharmaceuticals, Inc.
FIG 20 SWOT Analysis: Medunik USA
FIG 21 SWOT Analysis: CSL Limited
FIG 22 SWOT Analysis: Novo Nordisk A/S
FIG 23 Recent strategies and developments: Novartis AG
FIG 24 SWOT Analysis: Novartis AG
FIG 25 SWOT Analysis: Pfizer, Inc.
FIG 26 SWOT Analysis: Bristol Myers Squibb Company
FIG 27 Recent strategies and developments: Emmaus Life Sciences, Inc.
FIG 28 SWOT Analysis: Emmaus Life Sciences, Inc.